• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠神经内分泌肿瘤患者特定肠道症状对生活质量的影响。

Impact of Specific Bowel Symptoms on Quality of Life in Patients with Midgut Neuroendocrine Tumours.

机构信息

Department of Surgery, Ystad Hospital, VO Kirurgi, Lasarettet i Ystad, Kristianstadvägen 3, 271 33, Ystad, Sweden.

Institution of Clinical Sciences, Lund University, Lund, Sweden.

出版信息

World J Surg. 2021 Sep;45(9):2793-2803. doi: 10.1007/s00268-021-06146-9. Epub 2021 May 9.

DOI:10.1007/s00268-021-06146-9
PMID:33969447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8321966/
Abstract

INTRODUCTION

Patients with midgut neuroendocrine tumours (NETs) suffer from decreased health-related quality of life (HRQoL), in large part due to bowel symptoms. However, it is unknown which bowel symptoms affect HRQoL the most. An enhanced understanding of this is essential to better focus treatment on this aspect of the disease. This study aimed to determine which bowel symptoms affect HRQoL the most in patients with midgut NETs.

METHODS

Consenting patients with midgut NET completed the Memorial Sloan Kettering Bowel Function Instrument and the HRQoL questionnaire (EORTC QLQ-C30). The correlation between bowel symptoms and HRQoL was analysed using multiple linear regression, adjusting for age, Charlson Comorbidity Index score, presence of metastatic disease, chromogranin A, and BMI yielding ß-coefficients with 95% confidence intervals.

RESULTS

Totally, 119 patients with midgut NET completed the questionnaires and were included in the study. Loose stool and bowel frequency ≥ 3/day were the most common bowel symptoms, reported by 47% and 56% of patients, respectively. However, sensitivity to certain types of food and beverages, a feeling of incomplete emptying of the bowel, and soiling were the symptoms most strongly correlated with decreased HRQoL, especially within domains concerning role and social function, with ß-coefficients for the strongest correlated symptoms of 15.0 and 14.6, respectively.

DISCUSSION

While symptoms concerning stool consistency and frequency are common in patients with midgut NET, our study suggests that other, more socially stigmatising symptoms affect patients' HRQoL more. Our findings could help caregivers understand patients' perceptions of the disease and provide avenues for more directed therapies.

摘要

简介

患有中肠神经内分泌肿瘤(NET)的患者生活质量相关健康状况(HRQoL)下降,在很大程度上是由于肠道症状。然而,尚不清楚哪些肠道症状对 HRQoL 的影响最大。深入了解这一点对于更好地关注疾病的这一方面至关重要。本研究旨在确定中肠 NET 患者中哪些肠道症状对 HRQoL 的影响最大。

方法

同意参加的中肠 NET 患者完成了纪念斯隆凯特琳肠道功能量表和 HRQoL 问卷(EORTC QLQ-C30)。使用多元线性回归分析肠道症状与 HRQoL 之间的相关性,调整年龄、Charlson 合并症指数评分、转移性疾病的存在、嗜铬粒蛋白 A 和 BMI,得出具有 95%置信区间的β系数。

结果

共有 119 名中肠 NET 患者完成了问卷调查并被纳入研究。稀便和每天排便≥3 次是最常见的肠道症状,分别有 47%和 56%的患者报告。然而,对某些类型的食物和饮料敏感、感觉肠道排空不完全和弄脏是与 HRQoL 下降最相关的症状,尤其是在角色和社会功能方面,相关性最强的症状的β系数分别为 15.0 和 14.6。

讨论

虽然中肠 NET 患者的粪便稠度和频率相关症状常见,但我们的研究表明,其他更具社会污名化的症状对患者的 HRQoL 影响更大。我们的研究结果可以帮助护理人员了解患者对疾病的看法,并为更有针对性的治疗提供途径。

相似文献

1
Impact of Specific Bowel Symptoms on Quality of Life in Patients with Midgut Neuroendocrine Tumours.肠神经内分泌肿瘤患者特定肠道症状对生活质量的影响。
World J Surg. 2021 Sep;45(9):2793-2803. doi: 10.1007/s00268-021-06146-9. Epub 2021 May 9.
2
Improved health-related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours.神经内分泌肿瘤患者在肽受体放射性核素治疗期间与健康相关的生活质量得到改善。
J Neuroendocrinol. 2023 Oct;35(10):e13342. doi: 10.1111/jne.13342. Epub 2023 Oct 8.
3
Health-Related Quality of Life for Long-Acting Octreotide versus Placebo in Patients with Metastatic Midgut Neuroendocrine Tumors in the Phase 3 PROMID Trial.在 3 期 PROMID 试验中,长效奥曲肽对比安慰剂用于治疗转移性中肠神经内分泌肿瘤患者的健康相关生活质量。
Neuroendocrinology. 2019;109(2):141-151. doi: 10.1159/000499469. Epub 2019 Mar 11.
4
Quality of Life in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy: Information from a Monitoring Program in Clinical Routine.胃肠胰神经内分泌瘤转移性患者接受肽受体放射性核素治疗后的生活质量:临床常规监测计划中的信息。
J Nucl Med. 2018 Oct;59(10):1566-1573. doi: 10.2967/jnumed.117.204834. Epub 2018 Jul 24.
5
Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors.高分化转移性胃肠胰神经内分泌肿瘤的健康相关生活质量
Cancer Metastasis Rev. 2015 Sep;34(3):381-400. doi: 10.1007/s10555-015-9573-1.
6
Health-Related Quality of Life in Patients with Small Intestine Neuroendocrine Tumors.小肠神经内分泌肿瘤患者的健康相关生活质量。
Neuroendocrinology. 2018;107(4):366-374. doi: 10.1159/000494293. Epub 2018 Oct 5.
7
Quality of life in patients with gastroenteropancreatic tumours: A systematic literature review.胃肠胰肿瘤患者的生活质量:系统文献回顾。
World J Gastroenterol. 2020 Jul 7;26(25):3686-3711. doi: 10.3748/wjg.v26.i25.3686.
8
Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.姑息化疗真的能缓解症状吗?我们的测量方法正确吗?一项关于晚期软组织肉瘤患者健康相关生活质量的混合方法纵向研究。
PLoS One. 2019 Sep 26;14(9):e0210731. doi: 10.1371/journal.pone.0210731. eCollection 2019.
9
Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS).胃肠胰神经内分泌肿瘤患者治疗中 EORTC QLQ-GINET21 问卷医师感知效用的多中心横断面调查(QUALINETS)。
Health Qual Life Outcomes. 2021 Jan 30;19(1):38. doi: 10.1186/s12955-021-01688-x.
10
Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study.探讨免疫检查点抑制剂治疗患者的健康相关生活质量:社交媒体研究。
J Med Internet Res. 2020 Sep 11;22(9):e19694. doi: 10.2196/19694.

引用本文的文献

1
Navigating care: understanding cancer patients' experiences with systemic radionuclide therapy.诊疗导航:了解癌症患者接受系统性放射性核素治疗的经历
Support Care Cancer. 2025 Mar 27;33(4):325. doi: 10.1007/s00520-025-09380-2.
2
Relationship between somatostatin receptor expressing tumour volume and health-related quality of life in patients with metastatic GEP-NET.生长抑素受体表达肿瘤体积与转移性 GEP-NET 患者健康相关生活质量的关系。
J Neuroendocrinol. 2022 Jun;34(6):e13139. doi: 10.1111/jne.13139. Epub 2022 Apr 29.

本文引用的文献

1
Bowel dysfunction after sigmoid resection for cancer and its impact on quality of life.乙状结肠切除术后的肠道功能障碍及其对生活质量的影响。
Br J Surg. 2019 Jan;106(1):142-151. doi: 10.1002/bjs.10979. Epub 2018 Sep 13.
2
Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-controlled Study of Telotristat Ethyl.理解类癌综合征患者体验:替利曲塞乙酯随机、安慰剂对照研究的退出访谈。
Clin Ther. 2017 Nov;39(11):2158-2168. doi: 10.1016/j.clinthera.2017.09.013. Epub 2017 Oct 23.
3
Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs.患者报告的神经内分泌肿瘤(NET)诊断负担:NET患者首次全球调查结果
J Glob Oncol. 2016 Jun 8;3(1):43-53. doi: 10.1200/JGO.2015.002980. eCollection 2017 Feb.
4
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.美国神经内分泌肿瘤患者的发病率、患病率和生存结局趋势。
JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589.
5
Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study.使用兰瑞肽Autogel/长效注射剂治疗类癌综合征的患者报告结局:一项国际观察性研究。
Dig Liver Dis. 2016 May;48(5):552-558. doi: 10.1016/j.dld.2015.12.013. Epub 2016 Jan 15.
6
Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors.高分化转移性胃肠胰神经内分泌肿瘤的健康相关生活质量
Cancer Metastasis Rev. 2015 Sep;34(3):381-400. doi: 10.1007/s10555-015-9573-1.
7
Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours.验证 EORTC QLQ-GINET21 问卷用于评估胃肠道神经内分泌肿瘤患者的生活质量。
Br J Cancer. 2013 Feb 5;108(2):301-10. doi: 10.1038/bjc.2012.560. Epub 2013 Jan 15.
8
Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer.低位前切除综合征评分:基于症状的直肠癌低位前切除术后肠功能障碍评分系统的开发和验证。
Ann Surg. 2012 May;255(5):922-8. doi: 10.1097/SLA.0b013e31824f1c21.
9
Comparison of health-related quality of life in patients with neuroendocrine tumors with quality of life in the general US population.比较神经内分泌肿瘤患者与一般美国人群的健康相关生活质量。
Pancreas. 2012 Apr;41(3):461-6. doi: 10.1097/MPA.0b013e3182328045.
10
The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer.一种用于评估直肠癌保肛手术后肠道功能的经过验证的工具的开发。
Dis Colon Rectum. 2005 Jul;48(7):1353-65. doi: 10.1007/s10350-004-0942-z.